1 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! Nov 21, 2024
3 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Aug 05, 2024
Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Disease Women who are prone to three types of gynecological inflammation in autumn should be alert! Nov 19, 2024
Read More Disease Helicobacter Pylori Is The Biggest "Bane" Of Stomach Cancer In China, 3 Ways To Effectively Eradicate It Nov 02, 2024
